Related content

Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study

By Tang Thomas   Glanville Julie   Hayden Catherine J.   White Davinia   Barth Julian H.   Balen Adam H.  

Human Reproduction, Vol. 21, Iss. 1, 2006-01 ,pp. : 80-89

Oxford University Press

Access to resources Recommend Favorite

Acarbose in obese patients with polycystic ovarian syndrome: a double-blind, randomized, placebo-controlled study

By Penna I.A.A.  

Human Reproduction, Vol. 20, Iss. 9, 2005-09 ,pp. : 2396-2401

Oxford University Press

Access to resources Recommend Favorite

Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study

By Sahin I   Serter R   Karakurt F   Demirbas B   Culha C   Taskapan C   Kosar F   Aral Y  

Gynecological Endocrinology, Vol. 19, Iss. 3, 2004-09 ,pp. : 115-124

Informa Healthcare

Access to resources Recommend Favorite

Combined metformin and clomiphene citrate versus highly purified FSH for ovulation induction in clomiphene-resistant PCOS women: a randomised controlled trial

By Abu Hashim Hatem   Wafa Alaa   El Rakhawy Mohamed  

Gynecological Endocrinology, Vol. 27, Iss. 3, 2011-03 ,pp. : 190-196

Informa Healthcare

Access to resources Recommend Favorite

Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response

By Palomba Stefano   Falbo Angela   Russo Tiziana   Orio Francesco   Tolino Achille   Zullo Fulvio  

Human Reproduction, Vol. 25, Iss. 4, 2010-04 ,pp. : 1005-1013

Oxford University Press

Access to resources Recommend Favorite